Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析

◆英語タイトル:Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH57663FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Anavex Life Sciences Corp (AVXL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and other central nervous systems (CNS) diseases, pain and various types of cancer. The company’s target indications include Alzheimer’s disease, Parkinson’s disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer infantile spasms, fragile X syndrome, Angelman syndrome, multiple sclerosis, depression, stroke, frontotemporal dementia, visceral pain, acute and neuropathic Pain and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study. Anavex’s lead compound ANAVEX 2-73 is being developed for the treatment of Alzheimer’s disease, Parkinson’s disease and potentially other CNS diseases, including rare diseases. Anavex is headquartered in New York, the US.

Anavex Life Sciences Corp Key Recent Developments

Feb 22,2021: Anavex Life Sciences announces participation at upcoming Worldwide National Institutes of Health (NIH) panel at Rare Disease Day
Feb 19,2021: Anavex Life Sciences announces participation at Precision in Clinical Trials Virtual Summit
Feb 11,2021: Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
Feb 08,2021: Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
Dec 28,2020: Anavex Life Sciences reports fiscal 2020 year end financial results and clinical program updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Anavex Life Sciences Corp – Key Facts
Anavex Life Sciences Corp – Key Employees
Anavex Life Sciences Corp – Key Employee Biographies
Anavex Life Sciences Corp – Major Products and Services
Anavex Life Sciences Corp – History
Anavex Life Sciences Corp – Company Statement
Anavex Life Sciences Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Anavex Life Sciences Corp – Business Description
R&D Overview
Anavex Life Sciences Corp – Corporate Strategy
Anavex Life Sciences Corp – SWOT Analysis
SWOT Analysis – Overview
Anavex Life Sciences Corp – Strengths
Anavex Life Sciences Corp – Weaknesses
Anavex Life Sciences Corp – Opportunities
Anavex Life Sciences Corp – Threats
Anavex Life Sciences Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Anavex Life Sciences Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 22, 2021: Anavex Life Sciences announces participation at upcoming Worldwide National Institutes of Health (NIH) panel at Rare Disease Day
Feb 19, 2021: Anavex Life Sciences announces participation at Precision in Clinical Trials Virtual Summit
Feb 11, 2021: Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
Feb 08, 2021: Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
Dec 28, 2020: Anavex Life Sciences reports fiscal 2020 year end financial results and clinical program updates
Aug 06, 2020: Anavex Life Sciences reports fiscal 2020 third quarter financial results and provides business updates
May 07, 2020: Anavex Life Sciences reports fiscal 2020 second quarter financial results and provides business updates
Mar 31, 2020: Anavex Life Sciences provides update on clinical program development as response to covid-19
Feb 06, 2020: Anavex Life Sciences reports fiscal 2020 first quarter financial results and provides clinical study updates
Feb 04, 2020: Anavex Life Sciences to present and participate in a panel at the 2020 BIO CEO & Investor Conference
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Anavex Life Sciences Corp, Key Facts
Anavex Life Sciences Corp, Key Employees
Anavex Life Sciences Corp, Key Employee Biographies
Anavex Life Sciences Corp, Major Products and Services
Anavex Life Sciences Corp, History
Anavex Life Sciences Corp, Subsidiaries
Anavex Life Sciences Corp, Key Competitors
Anavex Life Sciences Corp, Ratios based on current share price
Anavex Life Sciences Corp, Annual Ratios
Anavex Life Sciences Corp, Interim Ratios
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Anavex Life Sciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Solvay Group:企業のM&A・事業提携・投資動向
    Solvay Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solvay Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Camel-IDS NV-製薬・医療分野:企業M&A・提携分析
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on …
  • Essential Energy Services Ltd (ESN):企業の財務・戦略的SWOT分析
    Summary Essential Energy Services Ltd (Essential Energy) operates as an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipmen …
  • Digimarc Corp (DMRC):企業の財務・戦略的SWOT分析
    Summary Digimarc Corp (Digimarc) is a technology company that offers develops solutions, license intellectual property and provides development services to businesses and government. The company offers products such as digimarc discover, online image safeguards and digimarc guardian. Digimarc’s Disc …
  • DJO Finance LLC:企業の戦略的SWOT分析
    DJO Finance LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Lanco Infratech Ltd:発電所・企業SWOT分析
    Lanco Infratech Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • American Tower Corporation:企業の戦略・SWOT・財務情報
    American Tower Corporation - Strategy, SWOT and Corporate Finance Report Summary American Tower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Siemens Healthineers.:企業の戦略・SWOT・財務情報
    Siemens Healthineers. - Strategy, SWOT and Corporate Finance Report Summary Siemens Healthineers. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ABITEC Corp:企業の戦略的SWOT分析
    ABITEC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Lisega SE:企業の戦略的SWOT分析
    Lisega SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • SM Energy Company:企業の戦略・SWOT・財務情報
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EnGeneIC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • True Diagnostics Inc:企業の製品パイプライン分析2018
    Summary True Diagnostics Inc (True Diagnostics) is a research, development and manufacturing company that offers in-vitro immunodiagnostic test systems and reagents. The company provides diagnostics such as self testing, point of care testing and companion diagnostics. It offers trueDX platform tech …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Unilife Corporation (UNIS)-医療機器分野:企業M&A・提携分析
    Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company's product port …
  • Strike Energy Ltd (STX):石油・ガス:M&Aディール及び事業提携情報
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆